Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Natalizumab treatment for multiple sclerosis.
Neutrophil-related factors as biomarkers in EAE and MS.
Association between the CD24 Ala57Val polymorphism and risk for multiple sclerosis and systemic lupus erythematosus: a meta-analysis.
Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients.
Imaging in multiple sclerosis and related disorders.
Janus Faces of Amyloid Proteins in Neuroinflammation.
The Prognostic Utility of MRI in Clinically Isolated Syndrome: A Literature Review.
[Depression and neurological diseases].
Evaluation of brainstem involvement in multiple sclerosis.
The effect of rhythmic-cued motor imagery on walking, fatigue and quality of life in people with multiple sclerosis: A randomised controlled trial.
T1- vs. T2-based MRI measures of spinal cord volume in healthy subjects and patients with multiple sclerosis.
Myeloid cell-based therapies in neurological disorders: How far have we come?
The redox state of the alarmin HMGB1 is a pivotal factor in neuroinflammatory and microglial priming: a role for the NLRP3 inflammasome.
Implementing technology-based embedded assessment in the home and community life of individuals aging with disabilities: a participatory research and development study.
Menopause in multiple sclerosis: therapeutic considerations.
Neuroimmunology: Aquaporin-4-antibody-seronegative neuromyelitis optica is less common than previously thought.
Occurrence of adverse events in chronic intrathecal baclofen infusion: a one-year follow-up study of 158 adults.
Study of fatigue frequency and its association with sociodemographic and clinical variables in patients with multiple sclerosis.
Multi-Sectional Views Textural Based SVM for MS Lesion Segmentation in Multi-Channels MRIs.
Abstracts of the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis. October 10-13, 2012. Lyon, France.
Biological monitoring of IFN-β therapy in Multiple Sclerosis.
Multiple sclerosis: Quadrivalent HPV vaccination does not increase risk of MS.
Natalizumab analogon therapy is effective in a B cell-dependent multiple sclerosis model.
MRI relaxation in the presence of fictitious fields correlates with myelin content in normal rat brain.
Focal transient CNS vessel leak provides a tissue niche for sequential immune cell accumulation during the asymptomatic phase of EAE induction.
Pages
« first
‹ previous
…
441
442
443
444
445
446
447
448
449
…
next ›
last »